Search research articles
Contact Us
Filters
Showing results (671-680 of 681) with videos related to
Page
of 69
Sort By:
Science Translational Medicine
|
June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Immunity
|
November 14, 2025
FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry
Jennifer M Umhoefer, Maya M Arce, Sivakanthan Kasinathan, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected
F Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
D Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active site
S K Thompson, S M Halbert, M J Bossard, et al.
Cancer Discovery
|
May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
Garrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Nature
|
June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activation
Dimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature
|
August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Dimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Journal of Medicinal Chemistry
|
April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin K
R W Marquis, Y Ru, S M LoCastro, et al.
Page
of 69
Search research articles
Search
Showing results (671-680 of 681) with videos related to
Sort By:
Page
of 69
Science Translational Medicine
|
June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Immunity
|
November 14, 2025
FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry
Jennifer M Umhoefer, Maya M Arce, Sivakanthan Kasinathan, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected
F Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
D Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active site
S K Thompson, S M Halbert, M J Bossard, et al.
Cancer Discovery
|
May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
Garrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Nature
|
June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activation
Dimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature
|
August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Dimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Journal of Medicinal Chemistry
|
April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin K
R W Marquis, Y Ru, S M LoCastro, et al.
Page
of 69